For example, high FDX1 expression in cancer stem cells decreased proliferation and overturned the epithelial–mesenchymal transition via tumor resistance to ammonified in human melanoma and promoted the treatment of resistant acute myeloid leukemia. The gene discussed is FDX1; the disease is neoplasm.